Gabapentin for postherpetic neuralgia [4] (multiple letters)

JAMA

Volumn 282, Issue 2, 1999, Pages 134-135

  Colman, E ^a   Stadel, B V ^a   Rowbotham, M C ^a   Magnus Miller, L ^a   Bernstein, P ^a  

^a CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GABAPENTIN;

CELLULITIS; CEREBROVASCULAR ACCIDENT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; GASTROINTESTINAL SYMPTOM; HEART DISEASE; HUMAN; INFECTION; LETTER; MAJOR CLINICAL STUDY; POSTHERPETIC NEURALGIA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

EID: 0033554087     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.282.2.134     Document Type: Letter

References (0)